MindCotine wants you to kick the smoking habit, and it is enlisting virtual reality to help.
The Redwood City, Calif.-based company has created a VR app that combines mindfulness practices, psychological therapies, and community engagement to fight nicotine addiction, and it has launched a Kickstarter crowdfunding campaign to raise $18,000 for the project.
The company is announcing the effort on the World Health Organization’s (WHO) World No Tobacco Day. The campaign aims to continue funding the development and worldwide distribution of the groundbreaking app.
MindCotine’s creators realized that the needs of smokers looking to quit were not being met. With the premise that smokers do not have convenient tools or programs handy to treat their addiction, the team combined their diverse expertise in the medical and virtual reality fields to engineer an easily accessible mobile application.
The app guides users through a mental process focused on raising awareness of the present moment and includes a biofeedback monitoring system that trains users to control their bodily processes. As users become conscious of what the habit represents for them, they are able to better identify and take charge of their impulses and behavior. The program also provides users with tools to overcome the cravings and discomfort associated with tobacco withdrawal.
Above: MindCotine’s kit for quitting smoking. / Image Credit: MindCotine
MindCotine uses a community platform with an artificial intelligence component. Users are welcome to join and practice the skills they’ve acquired, as well as supporting peers in overcoming their addiction.
According to the World Health Organization (WHO), smoking causes approximately 6 million deaths per year and is responsible for $1 trillion in health care costs worldwide.
Governments and other entities around the world have taken measures to address this problem, proposing a broad variety of solutions, from taxation and bans to awareness campaigns to nicotine-related therapies, such as nicotine patches and prescription medications.
MindCotine is undergoing validation and trials in focus groups at universities around the world, including Universidad Siglo 21 in Argentina and Universidad de la Comunicación in Mexico City.